DSM Nutritional Products Inc.
April 26, 2004
DSM Nutritional Products Inc.
EGCG Treatment Reverses Endothelial Dysfunction in Patients with CoronaryArtery Disease
PARSIPPANY,N.J.Epidemiological studies suggest consumption of flavonoid-containingfoods reduces cardiovascular risk. Basic studies suggest one possible mechanismfor this is improved endothelial function. A recent double blind,placebo-controlled study using TEAVIGO epigallocatechin gallate (EGCG) foundthe extract significantly reversed endothelium dysfunction in 42 patients withcoronary artery disease. Joseph A. Vita, M.D., from Boston Medical Center willdiscuss the study of TEAVIGO, a trademarked ingredient from DSM NutritionalProducts.
The VendorWorks presentation will be given Thursday, May 6, from 4 to 4:50p.m. at SupplySide East. For additional information, visit www.dsmnutritionalproducts.comor Booth #1347.
You May Also Like